Applicability of an arm exoskeleton for persons with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy

Applicability of an arm exoskeleton for persons with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy - Arm exoskeleton for DMD and SMA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON45622

Enrollment

Registered

2017-05-18

Start date

2017-02-20

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DMD / Spinal Musclular Atrophy Duchenne Muscular Dystrophy SMA

Interventions

Duchenne Muscular Dystrophy

Exoskeleton

Spinal Muscular Atrophy

Upper extremity

Eligibility

Age

2 Years to 64 Years

Inclusion criteria

Inclusion criteria: DNA established diagnosis of DMD or SMA Brooke scale 1 to 4 Ambuland and non-ambulant

Exclusion criteria

Exclusion criteria: Participants younger than 7 years Other disabling diseases influencing upper extremity function

Design outcomes

Primary

Measure	Time frame
The most important outcome measures are: maximal muscle force, active range of motion, muscle activity measured with surface electromyography and trunk impairment score.	—

Secondary

Measure	Time frame
Secundary outcome measures are: passieve range of motion, trunk balance and stability, performance of upper limb scale, 9-hole peg test, Timed_TIHM en Brooke scale.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)